Montelukast and depressive symptoms (2007) Conclusion The fact that the patients (except for one) did not suffer from depressive symptoms before they started montelukast, the short latency, and recovery after withdrawal of the drug all strengthen our hypothesis that depressive symptoms are an ADR related to the use of montelukast. According to the Marketing Authorisation Holder of montelukast, depression will be added to the product information. lareb.nl/Signalen/kwb_2006_4_montel
Posted on: Sun, 24 Aug 2014 06:51:39 +0000